Business Today
Subscribe
PMS TodayBudget 2025US NewsIndiaWeatherBT ShortsNRIEducationElection
BT GolfBT India 100BT Mindrush
Search
Advertisement
Business News
markets
stocks
Zim Laboratories Ltd
Zim Laboratories Ltd

Zim Laboratories Ltd (ZIMLAB) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 43,633
Dec 05, 2025
  • NSE
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹71.41
₹0.41 (0.58%)
70.00Low
Today’s Performance
72.00High
67.00Low
52 Week’s Performance
127.00High

bt_logoStock Analysis

bt_logoStock Performance

  • 1 Day0.58%
  • 1 Week-1.72%
  • 1 Month0.83%
  • 3 Months-3.19%
  • 6 Months-30.30%
  • 1 Year-41.59%
  • 3 Years-12.61%
  • 5 Years-%

bt_logoStock Summary

  • Face Value (₹)10.00
  • Beta0.85
  • 52-Week Low (₹)67.00
  • 52-Week High (₹)127.00
  • Price-to-Book (X)*1.37
  • Dividend Yield (%)-
  • Price-to-Earnings (P/E) (X)*52.36
  • Earnings Per Share (₹)1.35
  • Market Cap (₹ Cr.)*348.02
* Values as of last close price

bt_logoCOMPETITORS

BT TV

"We Share, Not Just Sell”: Putin Reveals India–Russia Defence Upgrade & Nuclear Plans | Exclusive5:31"We Share, Not Just Sell”: Putin Reveals India–Russia Defence Upgrade & Nuclear Plans | Exclusive
Ground Report From IGI Counters: Stranded Flyers Slam IndiGo Amid Widespread Cancellations7:17Ground Report From IGI Counters: Stranded Flyers Slam IndiGo Amid Widespread Cancellations
FM Sitharaman Clarifies Cess On Demerit Goods: Fungible Funds For Defence, Public Health Support5:04FM Sitharaman Clarifies Cess On Demerit Goods: Fungible Funds For Defence, Public Health Support
India–Russia Trade to Cross $100 Billion Before 2030: PM Modi Fast-Tracks Economic Partnership2:31India–Russia Trade To Cross $100 Billion Before 2030: PM Modi Fast-Tracks Economic Partnership
Russia Eyes Indian Workforce, New Trade Plan And Tariff Cuts In Major Economic Push11:22Russia Eyes Indian Workforce, New Trade Plan And Tariff Cuts In Major Economic Push
IndiGo CEO Pieter Elbers Admits Worst-Ever Disruption As Over 1,000 Flights Cancelled Nationwide3:48IndiGo CEO Pieter Elbers Admits Worst-Ever Disruption As Over 1,000 Flights Cancelled Nationwide
India & Russia Plan Faster Trade Routes, Digital Corridors & New Nuclear Opportunities2:42India & Russia Plan Faster Trade Routes, Digital Corridors & New Nuclear Opportunities
Passengers Angry Over IndiGo Delays, Complain Of No Information3:16Passengers Angry Over IndiGo Delays, Complain Of No Information
Vikram Misri: India–Russia to Accelerate FTA, Investment Treaty and Key Connectivity Negotiations1:58Vikram Misri: India–Russia To Accelerate FTA, Investment Treaty And Key Connectivity Negotiations
‘If US Can Buy Russian Fuel, Why Not India?’: Putin Challenges Trump’s Claim On Ukraine War3:01‘If US Can Buy Russian Fuel, Why Not India?’: Putin Challenges Trump’s Claim On Ukraine War
View more

bt_logoFAQ's

What was Zim Laboratories Ltd share price previously?
Zim Laboratories Ltd share price was up by 0.58% from the previous closing price of ₹71.00.
Who are peers of Zim Laboratories Ltd?
The peers of Zim Laboratories Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Torrent Pharmaceuticals Ltd, Cipla Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd, Zydus Lifesciences Ltd.
Who is/are the promoter/promoters of Zim Laboratories Ltd?
The promotor/promotors of Zim Laboratories Ltd are Anwar S Daud, Zulfiquar M Kamal, Prakash Sapkal, Niraj Dhadiwal, Kavita Loya, Padmakar Joshi, Piyush Nikhadi, Kamlesh Shende, Ashok Bhatia.
What has been 52-week high of Zim Laboratories Ltd stocks?
The highest price of Zim Laboratories Ltd stock is ₹127.00 in the last 52-week.
What is the share price of Zim Laboratories Ltd (ZIMLAB) today on NSE?
As on Dec 05, 2025 Zim Laboratories Ltd (ZIMLAB)’s share price on NSE is Rs 71.41
What is the market cap of Zim Laboratories Ltd (ZIMLAB)?
The current market capitalisation of Zim Laboratories Ltd (ZIMLAB) is 348.02 crores
What is Zim Laboratories Ltd Share symbol?
The symbol of Zim Laboratories Ltd is ZIMLAB.
What is the PE ratio of Zim Laboratories Ltd (ZIMLAB)?
The current PE ratio of Zim Laboratories Ltd (ZIMLAB) is 52.36.
What is the PB ratio of Zim Laboratories Ltd (ZIMLAB)?
The current PB ratio of Zim Laboratories Ltd (ZIMLAB) is 1.37.
Today’s High & Low share prices of Zim Laboratories Ltd (ZIMLAB) on NSE?
Today, the share price of Zim Laboratories Ltd (ZIMLAB) on NSE touched a high of Rs 72 and a low of Rs 70
What price did Zim Laboratories Ltd (ZIMLAB) shares open on the NSE today?
On NSE, the share price of Zim Laboratories Ltd (ZIMLAB) opened at Rs 70
What is the 52-week high of Zim Laboratories Ltd (ZIMLAB)?
The 52-week high price of Zim Laboratories Ltd (ZIMLAB) is Rs 127.00
What is the 52-week low of Zim Laboratories Ltd (ZIMLAB)?
The 52-week low price of Zim Laboratories Ltd (ZIMLAB) is Rs 67.00

bt_logoAbout Zim Laboratories

Zim Laboratories Ltd, incorporated in the year 1984, has its registered office in Sadoday Gyan (Gr Floor), Opp NADT Nelson Square, Nagpur, Maharashtra, 440013, 91-712-2588070. The main industry in which Zim Laboratories Ltd operates is Pharmaceuticals - Indian - Bulk Drugs & Formln.

Auditor/Auditors for Zim Laboratories Ltd is/are Walker Chandiok & Co LLP. In the main management, Anwar S Daud is chairman and Piyush Nikhadi is the company secretary for Zim Laboratories Ltd.

  • ASD
    Anwar S DaudChairman & Managing Director
  • ZMK
    Zulfiquar M KamalDirector (Finance)
  • PS
    Prakash SapkalWhole Time Director
  • ND
    Niraj DhadiwalDirector (Business Development)
  • KL
    Kavita LoyaIndependent Director
  • PJ
    Padmakar JoshiIndependent Director
  • PN
    Piyush NikhadiCompany Sec. & Compli. Officer
  • KS
    Kamlesh ShendeIndependent Director
  • AB
    Ashok BhatiaIndependent Director

bt_logoTop Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.